Profile | GDS5420 / 212649_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 441.63 | 65 |
GSM1296119 | B_lesional_pre-dose | 698.74 | 73 |
GSM1296076 | C_lesional_pre-dose | 387.25 | 65 |
GSM1296092 | D_lesional_pre-dose | 346.63 | 62 |
GSM1296103 | E_lesional_pre-dose | 458.44 | 66 |
GSM1296078 | F_lesional_pre-dose | 367.2 | 64 |
GSM1296107 | G_lesional_pre-dose | 936.68 | 78 |
GSM1296109 | H_lesional_pre-dose | 1315.54 | 84 |
GSM1296080 | I_lesional_pre-dose | 270.77 | 58 |
GSM1296090 | J_lesional_pre-dose | 370.37 | 63 |
GSM1296074 | K_lesional_pre-dose | 372.61 | 64 |
GSM1296111 | L_lesional_pre-dose | 978.85 | 79 |
GSM1296099 | M_lesional_pre-dose | 556.76 | 69 |
GSM1296086 | O_lesional_pre-dose | 498.36 | 68 |
GSM1296117 | P_lesional_pre-dose | 964.39 | 79 |
GSM1296113 | Q_lesional_pre-dose | 894.56 | 78 |
GSM1296096 | R_lesional_pre-dose | 592.11 | 70 |
GSM1296105 | S_lesional_pre-dose | 450.16 | 65 |
GSM1296098 | T_lesional_pre-dose | 565.47 | 69 |
GSM1296101 | U_lesional_pre-dose | 553.14 | 69 |
GSM1296121 | V_lesional_pre-dose | 797.49 | 76 |
GSM1296088 | W_lesional_pre-dose | 203.82 | 53 |
GSM1296082 | X_lesional_pre-dose | 380.52 | 64 |
GSM1296115 | Y_lesional_pre-dose | 986.29 | 79 |
GSM1296084 | Z_lesional_pre-dose | 232.28 | 55 |
GSM1296072 | B_lesional_day8 | 474.86 | 67 |
GSM1296069 | L_lesional_day8 | 964.3 | 79 |
GSM1296071 | P_lesional_day8 | 799.25 | 76 |
GSM1296070 | Y_lesional_day8 | 783.82 | 75 |
GSM1296073 | V_lesional_day8 | 658.65 | 73 |
GSM1296034 | A_lesional_day15 | 481.42 | 66 |
GSM1296041 | G_lesional_day15 | 923.64 | 78 |
GSM1296035 | R_lesional_day15 | 487.41 | 67 |
GSM1296038 | U_lesional_day15 | 199.42 | 52 |
GSM1296047 | B_lesional_day15 | 539.68 | 69 |
GSM1296039 | E_lesional_day15 | 356.35 | 62 |
GSM1296042 | H_lesional_day15 | 893.85 | 78 |
GSM1296043 | L_lesional_day15 | 913.59 | 78 |
GSM1296037 | M_lesional_day15 | 311.45 | 59 |
GSM1296046 | P_lesional_day15 | 842.72 | 76 |
GSM1296044 | Q_lesional_day15 | 877.45 | 77 |
GSM1296045 | Y_lesional_day15 | 743.03 | 74 |
GSM1296025 | C_lesional_day15 | 495.75 | 68 |
GSM1296033 | D_lesional_day15 | 343.61 | 61 |
GSM1296027 | I_lesional_day15 | 242.51 | 57 |
GSM1296032 | J_lesional_day15 | 418.53 | 64 |
GSM1296024 | K_lesional_day15 | 370.32 | 63 |
GSM1296031 | W_lesional_day15 | 402.94 | 63 |
GSM1296028 | X_lesional_day15 | 320.97 | 60 |
GSM1296029 | Z_lesional_day15 | 328.62 | 60 |
GSM1296026 | F_lesional_day15 | 296.89 | 60 |
GSM1296030 | O_lesional_day15 | 172.02 | 52 |
GSM1296040 | S_lesional_day15 | 679.52 | 73 |
GSM1296036 | T_lesional_day15 | 635.91 | 71 |
GSM1296048 | V_lesional_day15 | 659.09 | 72 |
GSM1296059 | A_lesional_day43 | 549.5 | 69 |
GSM1296066 | G_lesional_day43 | 943.34 | 79 |
GSM1296060 | R_lesional_day43 | 374.07 | 62 |
GSM1296063 | U_lesional_day43 | 408.42 | 65 |
GSM1296064 | E_lesional_day43 | 539.3 | 70 |
GSM1296067 | H_lesional_day43 | 734.34 | 74 |
GSM1296062 | M_lesional_day43 | 487.91 | 67 |
GSM1296068 | Q_lesional_day43 | 725.41 | 74 |
GSM1296050 | C_lesional_day43 | 290.67 | 59 |
GSM1296057 | D_lesional_day43 | 114.42 | 44 |
GSM1296052 | I_lesional_day43 | 273.04 | 58 |
GSM1296054 | J_lesional_day43 | 297.86 | 58 |
GSM1296049 | K_lesional_day43 | 360.45 | 62 |
GSM1296055 | W_lesional_day43 | 244.86 | 55 |
GSM1296053 | X_lesional_day43 | 364.04 | 62 |
GSM1296058 | Z_lesional_day43 | 106.3 | 43 |
GSM1296051 | F_lesional_day43 | 335.97 | 62 |
GSM1296056 | O_lesional_day43 | 164.57 | 50 |
GSM1296065 | S_lesional_day43 | 270.44 | 57 |
GSM1296061 | T_lesional_day43 | 583.09 | 70 |
GSM1296095 | A_non-lesional_pre-dose | 440.2 | 66 |
GSM1296120 | B_non-lesional_pre-dose | 548.07 | 69 |
GSM1296077 | C_non-lesional_pre-dose | 492.25 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 391.78 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 344.49 | 61 |
GSM1296079 | F_non-lesional_pre-dose | 432.46 | 66 |
GSM1296108 | G_non-lesional_pre-dose | 838.67 | 76 |
GSM1296110 | H_non-lesional_pre-dose | 911.31 | 78 |
GSM1296081 | I_non-lesional_pre-dose | 371.05 | 63 |
GSM1296091 | J_non-lesional_pre-dose | 248.23 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 260.22 | 58 |
GSM1296112 | L_non-lesional_pre-dose | 733.97 | 74 |
GSM1296100 | M_non-lesional_pre-dose | 389.1 | 63 |
GSM1296087 | O_non-lesional_pre-dose | 245.27 | 57 |
GSM1296118 | P_non-lesional_pre-dose | 892.28 | 77 |
GSM1296114 | Q_non-lesional_pre-dose | 862.67 | 77 |
GSM1296097 | R_non-lesional_pre-dose | 296.5 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 402.48 | 63 |
GSM1296102 | U_non-lesional_pre-dose | 606.03 | 70 |
GSM1296122 | V_non-lesional_pre-dose | 621.7 | 71 |
GSM1296089 | W_non-lesional_pre-dose | 219.76 | 53 |
GSM1296083 | X_non-lesional_pre-dose | 568.37 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 954.37 | 79 |
GSM1296085 | Z_non-lesional_pre-dose | 412.96 | 64 |